tiprankstipranks
Advertisement
Advertisement

Medibank lifts policyholder growth as value-focused strategy drives earnings momentum

Story Highlights
  • Medibank is growing resident and non-resident health insurance memberships while lifting Medibank Health profits about 30% year-to-date.
  • Amid an evolving, value-driven PHI market, Medibank is pursuing disciplined, customer-focused growth via hospital partnerships, direct channels and enhanced benefits.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Medibank lifts policyholder growth as value-focused strategy drives earnings momentum

Meet Samuel – Your Personal Investing Prophet

An announcement from Medibank Private ( (AU:MPL) ) is now available.

Medibank Private reports continued growth in its resident private health insurance business, with policyholder numbers up 22.4k in the nine months to 31 March 2026, supported by stronger Medibank brand performance and soft hospital claims utilisation. The company is also seeing solid non-resident growth, with policy units up 8.1k in the third quarter, and Medibank Health operating profit about 30% higher year-to-date, underpinned by rising volumes, new services and acquisitions.

Management highlights that the Australian private health insurance industry is expanding but evolving as consumers increasingly prioritise value and shift to lower-premium, lower-cover products, intensifying price-led competition. Medibank is responding with a disciplined, value-focused strategy that includes partnership-based hospital funding models, reduced reliance on aggregators for ahm, expanded no-gap joint replacement options, and continued investment in customer benefits such as reduced out-of-pocket costs and rewards, while reaffirming its existing FY26 outlook.

The most recent analyst rating on (AU:MPL) stock is a Hold with a A$4.80 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.

More about Medibank Private

Medibank Private is a leading Australian private health insurer providing resident and non-resident private health insurance, alongside broader health services such as primary care and virtual GP offerings. The group operates the Medibank and ahm brands and partners with private hospitals and universities, with a focus on affordability, customer value and sustainable growth in the domestic health market.

YTD Price Performance: 0.43%

Average Trading Volume: 7,829,825

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$13B

See more insights into MPL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1